Viral Infections and Type 1 Diabetes

Infection and Autoimmunity, 2nd edition

Volumn , Issue , 2004, Pages 229-249

  Jun, Hee Sook ^a   Yoon, Ji Won ^a  

^a The Chicago Medical College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49349097262     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451271-0.50020-X     Document Type: Chapter

References (188)

1. Yoon JW, Jun HS Insulin-dependent diabetes mellitus. Encyclopedia of Immunology 1998, 1390-1398. Academic, London, UK. 2nd Ed. I.M. Roitt, P.J. Delves (Eds.).
2. Lernmark A, Falorni A Immune phenomena, events in the islets in insulin-dependent diabetes mellitus. Textbook of Diabetes 1997, 15.1-15.23. Blackwell Science, Oxford. 2nd Ed. J.C. Pickup, G. Williams (Eds.).
3. Bach JF Insulin-dependent diabetes mellitus as a β cell targeted disease of immunoregulation. J Autoimmunity 1995, 8:439-463.
4. Schranz DB, Lernmark A Immunology in diabetes: an update. Diab Metab Rev 1998, 14:3-29.
5. Tisch R, McDevitt H Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
6. Verge CF, Eisenbarth GS Prediction of type 1 diabetes: the natural history of the prediabetic period. Type 1 Diabetes: Molecular, Cellular and Clinical Immunology 1996, 230-258. Oxford Univ Press, New York, NY. G.S. Eisenbarth, K.J. Lafferty (Eds.).
7. Notkins AL Immunologic and genetic factors in type 1 diabetes. J Biol Chem 2002, 277:43545-43548.
8. Kelly MA, Rayner ML, Mijovic CH, Barnett AH Molecular aspects of type 1 diabetes. Mol Pathol 2003, 56:1-10.
9. Redondo MJ, Eisenbarth GS Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia 2002, 45:605-622.
10. Todd JA, Bain SC A practical approach to identification of susceptibility genes for IDDM. Diabetes 1992, 41:1029-1034.
11. She JX Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996, 17:323-329.
12. Segall M HLA and genetics of IDDM. Holism vs. reductionism?. Diabetes 1988, 37:1005-1008.
13. Yoon JW, Jun HS Role of viruses in the pathogenesis of type 1 diabetes mellitus. Diabetes Mellitus: A Fundamental and Clinical Text 2000, 419-430. Lippincott-Ravin, Philadelphia. D. LeRoith, M. Olefsky (Eds.).
14. Jun HS, Yoon JW A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 2003, 19:8-31.
15. Hyoty H, Taylor KW The role of viruses in human diabetes. Diabetologia 2002, 45:1353-1361.
16. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 2002, 115:18-29.
17. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992, 35:1060-1067.
18. Kyvik KO, Green A, Beck-Nielsen H Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 1995, 311:913-917.
19. Barnett AH, Eff C, Leslie RD, Pyke DA Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981, 20:87-93.
20. Green A, Sjolie AK, Eshoj O The epidemiology of diabetes mellitus. Textbook of Diabetes 1997, 3.1-3.16. Blackwell Science, Oxford. 2nd Ed. J.C. Pickup, G. Williams (Eds.).
21. Jun HS, Yoon JW A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 2003, 19:8-31.
22. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE Coxsackie B-virus specific IgM responses in children with insulin-dependent diabetes mellitus. Lancet 1983, 1:1397-1399.
23. Banatvala JE, Bryant J, Schernthaner G, et al. Coxsackie B, mumps, rubella and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria and Australia. Lancet 1985, 1:1409-1412.
24. Friman G, Fohlman J, Frisk G, Diderholm H, Ewald U, Kobbah M, Tuvemo T An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response. Acta Pediatr Scand 1985, 320(Suppl):14-19.
25. Gamble DR, Kinsley ML, Fitzgerald MG, Bolton R, Taylor KW Viral antibodies in diabetes mellitus. Br Med J 1969, 3:627-630.
26. Mertens T, Gruneklee D, Eggers HJ Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type 1 diabetes. Eur J Pediatr 1983, 140:293-294.
27. Frisk G, Fohlman J, Kobbah M, et al. High frequency of Coxsackie-B-virus-specific IgM in children developing during a period of high diabetes morbidity. J Med Virol 1985, 17:219-227.
28. Fohlman J, Bohme J, Rask L, et al. Matching of host genotype and serotypes of Coxsackie B virus in the development of juvenile diabetes. Scand J Immunol 1987, 26:105-110.
29. Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 1992, 35:249-253.
30. Gamble DR, Taylor KW, Cumming H Coxsackie viruses and diabetes mellitus. Br Med J 1973, 4:260-262.
31. Wagenknecht L, Roseman J, Herman W Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackie virus B5. Am J Epidemiol 1991, 133:1024-1031.
32. Varela-Calvino R, Sgarbi G, Wedderburn LR, Dayan CM, Tremble J, Peakman M T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vβ usage without superantigenic activity. J Immunol 2001, 167:3513-3520.
33. Varela-Calvino R, Sgarbi G, Arif S, Peakman M T-Cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievirus B4. Virology 2000, 274:56-64.
34. Varela-Calvino R, Ellis R, Sgarbi G, Dayan CM, Peakman M Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes 2002, 51:1745-1753.
35. Palmer JP, Cooney MK, Crossley JR, Hollander PH, Asplin CM Antibodies to viruses and to pancreatic islets in nondiabetic and insulin-dependent diabetic patients. Diabetes Care 1981, 4:525-528.
36. Pagano G, Cavallo-Perin P, Cavallo TF, et al. Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12 month follow-up of an Italian population. Diabetes 1987, 36:859-863.
37. Marttila J, Juhela S, Vaarala O, et al. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology 2001, 284:131-141.
38. Pato E, Cour MI, Gonzalez-Cuadrado S, Gonzalez-Gomez C, Munoz JJ, Figueredo A Coxsackie B4 and cytomegalovirus in patients with insulin-dependent diabetes. Anales de Medicina Interna 1992, 9:30-32.
39. Palmer JP, Cooney MK, Ward RH, et al. Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection. Diabetologia 1982, 22:426-429.
40. Tuvemo T, Dahlquist G, Frisk G, et al. The Swedish childhood diabetes study III: IgM against Coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children-no evidence of increased antibody frequency. Diabetologia 1989, 32:745-747.
41. Prabhakar BS, Haspel MV, McClintock PR, Notkins AL High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies. Nature 1982, 300:374-376.
42. Yoon JW, Bachurski CJ, McArthur RG Concept of virus as an etiological agent in the development of IDDM. Diabetes Res Clin Pract 1986, 2:365-366.
43. Yoon JW, Onodera T, Notkins AL Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with Coxsackie virus B4. J Exp Med 1978, 148:1068-1080.
44. Clements GB, Galbraith DN, Taylor KW Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995, 346:221-223.
45. Andreoletti L, Hober D, Hober-Vandenberghe C, et al. Detection of Coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type 1 diabetes mellitus. J Med Virol 1997, 52:121-127.
46. Notkins AL, Yoon JW Virus-induced diabetes in mice prevented by a live attenuated vaccine. New Engl J Med 1982, 306:486.
47. Wilson C, Connolly JM, Thomson D Coxsackie B2 virus infection and acute onset diabetes in a child. Br Med J 1977, 1:1008.
48. Ahmad N, Abraham AA Pancreatic isletitis with Coxsackie virus B5 infection. Hum Pathol 1982, 13:661-662.
49. Asplin CM, Cooney MK, Crossley JR, Dornan TL, Raghu P, Palmer JP Coxsackie B4 infection and islet cell antibodies three years before overt diabetes. J Pediatr 1982, 101:398-400.
50. Orchard TJ, Becker AJ, Atchison RW, et al. The development of type 1 (insulin-dependent) diabetes mellitus: two contrasting presentations. Diabetologia 1982, 25:89-92.
51. Niklasson BS, Dobersen MJ, Peters CJ, Ennis WH, Moller E An outbreak of Coxsackie-virus B infection followed by one case of diabetes mellitus. Scand J Infect Dis 1985, 17:15-18.
52. Nigro G, Pacella ME, Patane E, Midulla M Multisystem Coxsackievirus B-6 infection with findings suggestive of diabetes mellitus. Eur J Paediatr 1986, 145:557-559.
53. Yoon JW, Austin M, Onodera T, Notkins AL Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979, 300:1173-1179.
54. Champsaur H, Bottazzo G, Bertrams J, Assan R, Bach C Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus. J Pediatrics 1982, 100:15-20.
55. Gladisch R, Hoffmann W, Waldherr R Myocarditis and insulitis following Coxsackie virus infection. Z Kardiol 1976, 65:837-849.
56. Yoon JW, Onodera T, Notkins AL Virus-induced diabetes mellitus. XI. Replication of Coxsackie virus B3 in human pancreatic beta cell cultures. Diabetes 1978, 27:778-782.
57. Szopa TM, Ward T, Taylor KW Impaired metabolic functions in human pancreatic islets following infection with Coxsackie B4 virus in vitro. Diabetologia 1986, 30:587A.
58. Toniolo A, Onodera T, Jordan G, Yoon JW, Notkins AL Virus induced diabetes mellitus: glucose abnormalities produced in mice by all six members of the Coxsackie B virus group. Diabetes 1982, 31:496-499.
59. Kaufman DL, Erlander MG, Clare-Salzler MJ, Atkinson MA, Maclaren NK, Tobin AJ Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992, 89:283-292.
60. Hou J, Sheikh S, Martin DL, Chatterjee NK Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection. J Autoimmun 1993, 6:529-542.
61. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from Coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994, 43:1260-1266.
62. Richter W, Mertens T, Schoel B, et al. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with Coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med 1994, 180:721-726.
63. Tian J, Lehmann PV, Kaufman DL T cell cross-reactivity between Coxsackie virus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994, 180:1979-1984.
64. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998, 4:781-785.
65. Foulis AK, Farquharson MA, Cameron SO, McGill M, Schonke H, Kandolf R A search for the presence of the enteroviral capsid protein VP1in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 1990, 33:290-298.
66. Foulis AK, Farquharson MA, Meager A Immunoreactive α-interferon in insulin-producing β cells in type I diabetes mellitus. Lancet 1987, 2:1423-1427.
67. Chehadeh W, Weill J, Vantyghem MC, et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackie B infection. J Infect Dis 2000, 181:1929-1939.
68. Yoon JW, Kominek HI Role of Coxsackie B viruses in the pathogenesis of diabetes mellitus. Microorganisms and Autoimmune Diseases 1996, 129-158. Plenum, New York. N.R. Rose, H. Friedman (Eds.).
69. Hiltunen M, Hyoty H, Knip M, et al. Childhood Diabetes in Finland (DiMe) Study Group. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997, 175:554-560.
70. Lonnrot M, Korpela K, Knip M, et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000, 49:1314-1318.
71. Helfand RF, Gary HE, Freeman CY, Anderson LJ, Pallansch MA Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. J Infect Dis 1995, 172:1206-1211.
72. Juhela S, Hyöty H, Roivainen M, et al. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes 2000, 49:1308-1313.
73. Lonnrot M, Salminen K, Knip M, et al. Childhood Diabetes in Finland (DiMe) Study Group. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. J Med Virol 2000, 61:214-220.
74. Nairn C, Galbraith DN, Taylor KW, Clements GB Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet Med 1999, 16:509-513.
75. Yin H, Berg AK, Tuvemo T, Frisk G Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002, 51:1964-1971.
76. Otonkoski T, Roivainen M, Vaarala O, et al. Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000, 43:1235-1238.
77. Vreugdenhil GR, Schloot NC, Hoorens A, et al. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways. Clin Infect Dis 2000, 31:1025-1031.
78. Lonnrot M, Knip M, Roivainen M, Koskela P, Akerblom HK, Hyoty H. Onset of type 1 diabetes mellitus in infancy after enterovirus infections. Diabet Med 199;15:431-444.
79. Graves PM, Norris JM, Pallansch MA, Gerling IC, Rewers M The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes 1997, 46:161-168.
80. Fohlman J, Friman G Is juvenile diabetes a viral disease?. Ann Med 1993, 25:569-574.
81. Frisk G, Nilsson E, Tuvemo T, Friman G, Diderholm H The possible role of Coxsackie A and echo viruses in the pathogenesis of type 1 diabetes mellitus studied by IgM analysis. J Infect 1992, 24:13-22.
82. Harris HF A case of diabetes mellitus quickly following mumps on the pathological alterations of salivary glands, closely resembling those found in pancreas, in a case of diabetes mellitus. Boston Med Sur J 1899, 140:465.
83. Gamble DR Relation of antecedent illness to development of diabetes in children. Br Med J 1980, 2:99-101.
84. Helmke K, Otten A, Willems W Islet cell antibodies in children with mumps infection. Lancet 1980, 2:211-212.
85. Cavallo MG, Baroni MG, Toto A, et al. Viral infection induces cytokine release by beta islet cells. Immunology 1992, 75:664-668.
86. Parkkonen P, Hyöty H, Koskinen L, Leinikki P Mumps virus infects Beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia 1992, 35:63-69.
87. Hummel M, Fuchtenbusch M, Schenker M, Ziegler AG No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care 2000, 24:969-974.
88. DeStafano F, Mullooly JP, Okoro CA, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001, 108:E112. Vaccine Safety Datalink Team.
89. Hyöty H, Hiltunen M, Reunanen A, et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Diabetologia 1993, 36:1303-1308.
90. Ginsberg-Fellner F, Fedun B, Cooper LZ, et al. Interrelationships of congenital rubella and type 1 insulin-dependent diabetes mellitus. The Immunology of Diabetes Mellitus 1986, 279-286. Elsevier, Amsterdam. M.A. Jaworski, G.D. Molnar, R.V. Rajotte, B. Singh (Eds.).
91. Patterson K, Chandra R, Jenson A Congenital rubella, insulitis and diabetes mellitus in an infant. Lancet 1981, 1:1048-1049.
92. Schopfer K, Matter L, Flueler U, Werder E Diabetes mellitus, endocrine autoantibodies and prenatal rubella infection. Lancet 1982, 2:159.
93. Menser MA, Forrest J, Bransby R Rubella infection and diabetes mellitus. Lancet 1978, 1:57-60.
94. Forrest J, Menser MA, Burgess J High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971, 1:332-334.
95. McEvoy R, Cooper L, Rubinstein P, Fedun B, Ginsberg-Feliner F Type I diabetes mellitus (IDDM) and autoimmunity in patients with congenital rubella syndrome (CRS): increased incidence of insulin autoantibodies. Diabetes 1986, 35:187A.
96. Rabinowe S, George K, Loughlin R, Soeldner J Predisposition to type I diabetes and organ-specific autoimmunity in congenital rubella: T cell abnormalities in young adults. Diabetes 1986, 35:187A.
97. Ginsberg-Feliner F, Witt ME, Fedun B Diabetes mellitus and autoimmunity in patients with congenital rubella syndrome. Rev Infect Dis 1985, 7(Suppl 1):170-175.
98. McIntosh EDG, Menser MA A fifty-year follow-up of congenital rubella. Lancet 1992, 340:414-415.
99. Ginsberg-Fellner F, Witt ME, Yagihaski S Congenital rubella-syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 1984, 27:87-89.
100. Numazaki K, Goldman H, Wong I, Wainberg MA Infection of cultured human fetal pancreatic islet cells by rubella virus. Am J Clin Pathol 1989, 91:446-451.
101. Numazaki K, Goldman H, Seemayer TA, Wong I, Wainberg MA Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans. In Vivo 1990, 4:49-54.
102. Karounos DG, Wolinsky JS, Thomas JW Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 1993, 150:3080-3085.
103. Ou D, Mitchell LA, Metzger DL, Gillam S, Tingle AJ Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognized by T cells of patients with type 1 diabetes mellitus. Diabetologia 2000, 43:750-762.
104. Ward KP, Galloway WH, Auchterlonie IA Congenital cytomegalovirus infection and diabetes. Lancet 1979, 1:497.
105. Yasumoto N, Hara M, Kitamoto YU, Nakayama M, Sato T Cytomegalovirus infection associated with acute pancreatitis, rhabdomyolysis and fenal failure. Intern Med 1992, 31:426-430.
106. Jenson A, Rosenberg H, Notkins AL Virus-induced diabetes mellitus XVII: Pancreatic islet cell damage in children with fatal vital infections. Lancet 1980, 2:354-358.
107. Pak CY, Eun HM, McArthur RG, Yoon JW Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988, 2:1-4.
108. Nicoletti F, Scalia G, Lunetta M, et al. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patient. Clin Immunol Immunopathol 1990, 55:139-147.
109. Pak CY, Cha CY, Rajotte RV, McArthur RG, Yoon JW Human pancreatic islet cell-specific 38 kDa autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia 1990, 33:569-572.
110. Hiemstra HS, Schloot NC, van Veelen PA, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001, 98:3988-3991.
111. Krieg AM, Steinberg AD Retroviruses and autoimmunity. J Autoimmun 1990, 3:137-166.
112. Krieg AM, Gourley MF, Perl A Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 1992, 6:2537-2544.
113. Perron H, Garson JA, Bedin F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 1997, 94:7583-7588.
114. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990, 250:1127-1129.
115. gag antigen. Cell 1987, 51:211-220.
116. Nyman U, Lundberg I, Hedfors E, Pettersson I Recombinant 70-kD protein used for determinantion of autoantigenic epitopes recognized by anti-RNP sera. Clin Exp Immunol 1990, 81:52-58.
117. Brookes SM, Pandolfino YA, Mitchell TJ, et al. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992, 31:735-742.
118. Hao W, Serreze DV, McCulloch DK, Neifing JL, Palmer JP Insulin (auto) antibodies from human IDDM cross-react with retroviral antigen p73. J Autoimmun 1993, 6:787-798.
119. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997, 90:303-313.
120. Kim A, Jun HS, Wong L, et al. Human endogenous retrovirus with a high genomic sequence homology with IDDMK(1,2)22 is not specific for Type I (insulin-dependent) diabetic patients but ubiquitous. Diabetologia 1999, 42:413-418.
121. Lower R, Tonjes RR, Boller K, et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 1998, 95:11-14.
122. Jaeckel E, Heringlake S, Berger D, Brabant G, Hunsmann G, Manns MP No evidence for association between IDDMK (1,2)22, a novel isolated retrovirus, and IDDM. Diabetes 1999, 48:209-214.
123. Stauffer Y, Marguerat S, Meylan F, et al. Interferonalpha-induced endogenous superantigen: a model linking environment and autoimmunity. Immunity 2001, 15:591-601.
124. Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P Immune responses to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. J Autoimmun 1994, 7:179-191.
125. Surcel HM, Ilonen J, Kaar ML, Hyöty H, Leinikki P Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes. Acta Paediatrica Scandinavica 1988, 77:471-474.
126. Sairenji T, Daibata M, Sorli CH, et al. Relating homology between the Epstein-Barr virus BOLF1 molecule and HLA-DQw8 beta chain to recent onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991, 34:33-39.
127. Horn G, Bugawan T, Long C, Erlich H Allelic sequence of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci USA 1988, 85:6012-6016.
128. Parkkonen F, Hyöty H, Ilonen J, Reijonen H, Yla-Herttuala S, Leinikki P Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 ß chain. Clin Exp Immunol 1994, 95:287-293.
129. Makeen AM The association of infective hepatitis type A (HAV) and diabetes mellitus. Tropical and Geographical Medicine 1992, 44:362-364.
130. Notkins AL Virus-induced diabetes mellitus. Arch Virol 1977, 54:1-17.
131. Fohlman J, Friman G Is juvenile diabetes a viral disease?. Ann Med 1993, 25:569-574.
132. Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000, 49:1319-1324.
133. Stefan Y, Malaisse-Lagae F, Yoon JW, Notkins AL, Orci L Virus-induced diabetes in mice: a quantitative evaluation of islet cell population by immunofluorescence technique. Diabetologia 1978, 15:395-401.
134. Craighead JE, McLane MF Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 1968, 162:913-915.
135. Yoon JW, Notkins AL Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replication of encephalomyocarditis virus in pancreatic B-cells. J Exp Med 1976, 143:1170-1185.
136. Jun HS, Yoon JW The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 2001, 44:271-285.
137. Yoon JW, McClintock PR, Onodera T, Notkins AL Virus-induced diabetes mellitus. Inhibition by a nondiabetogenic variant of encephalomvocarditis virus. J Exp Med 1980, 152:878-892.
138. Onodera T, Yoon JW, Brown K, Notkins AL Virus-induced diabetes mellitus: evidence for control by a single locus. Nature 1978, 274:693-696.
139. Kang Y, Yoon JW A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice. J Gen Virol 1993, 74:1203-1213.
140. Yoon JW, Lesniak MA, Fussganger R, Notkins AL Genetic differences in susceptibility of pancreatic ß cells to virus-induced diabetes mellitus. Nature 1976, 264:178-180.
141. Chairez R, Yoon JW, Notkins AL Virus-induced diabetes mellitus. X. Attachment of encephalomyocarditis virus and permissiveness of cultured ß cells to infection. Virology 1978, 85:606-611.
142. Bae YS, Eun HM, Yoon JW Molecular identification of viral gene. Diabetes 1989, 38:316-320.
143. Bae YS, Eun HM, Yoon JW Genomic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. Virology 1989, 170:282-287.
144. Bae YS, Yoon JW Determination of diabetogenicity attributable to a single amino acid, Ala-776, on the polyprotein of encephalomyocarditis virus. Diabetes 1993, 42:435-443.
145. Jun HS, Kang Y, Notkins AL, Yoon JW Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J Virol 1997, 71:9782-9785.
146. Jun HS, Kang Y, Yoon HS, Kim KH, Notkins AL, Yoon JW Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes 1998, 47:576-582.
147. Hirasawa K, Jun HS, Han HS, Zhang M-L, Hollenberg M, Yoon JW Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine signalling pathway and suppression of nitric oxide production in macrophages. J Virol 1999, 73:8541-8548.
148. Hirasawa K, Jun HS, Maeda K, et al. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 1997, 71:4024-4031.
149. Choi KS, Jun HS, Kim HN, et al. Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 2001, 75:1949-1957.
150. Yoon JW, Morishima T, McClintock PR, Austin M, Notkins AL Virus-induced diabetes mellitus: mengovirus infects pancreatic beta cells in strains of mice resistant to encephalomyocarditis virus. J Virol 1984, 50:684-690.
151. Kibrick S, Benirschke K Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with coxsackie virus, group B; evidence of intrauterine infection with this agent. Pediatrics 1958, 22:857-875.
152. Kuno S, Itagaki A, Yamazaki I, Katsumoto T, Kurimura T Pathogenicity of newly isolated coxsackievirus B4 for mouse pancreas. Acta Virol 1984, 28:433-436.
153. Szopa TM, Ward T, Dronfield DM, Portwood ND, Taylor KW Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 1990, 33:325-328.
154. Chatterjee NK, Haley TM, Nejman C Functional alterations in pancreatic beta cells as a factor in virus-induced hyperglycemia in mice. J Biol Chem 1985, 260:12786-12791.
155. Chatterjee NK, Hou J, Dockstader P, Charbonneau T Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J Med Virol 1992, 38:124-131.
156. Caggana M, Chan P, Ramsingh A Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol 1993, 67:4797-4803.
157. Jenkins O, Booth JD, Minor PD, Almond JW The complete nucleotide sequence of Coxsackievirus B4 and its comparison to other members of picornaviridae. J Gen Virol 1987, 68:1835-1848.
158. Kang Y, Chatterjee NK, Nodwell MJ, Yoon JW Complete nucleotide sequence of a strain of Coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with non-diabetogenic Coxsackie B4 JBV strain. J Med Virol 1994, 44:353-361.
159. Titchener PA, Jenkins O, Szopa TM, Taylor KW, Almond JW Complete nucleotide sequence of a betacell tropic variant of Coxsackievirus B4. J Med Virol 1994, 42:369-373.
160. Yoon JW, London W, Curfinan B, Brown R, Notkins AL Coxsackie virus B4 produces transient diabetes in nonhuman prirnates. Diabetes 1986, 53:712-716.
161. Prabhakar BS, Menegus MA, Notkins AL Detection of conserved and nonconserved epitopes on Coxsackie virus B4: frequency of antigenic change. Virology 1985, 146:302-306.
162. Guberski DL, Thomas VA, Shek WR, et al. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 1991, 254:1010-1013.
163. Brown DW, Welsh RM, Like AA Infection of peripancreatic lymph nodes but not islets precedes Kilham's rat virus-induced diabetes in BB/Wor rats. J Virol 1993, 67:5873-5878.
164. Chung YH, Jun HS, Hirasawa K, Lee BR, van Rooijen N, Yoon JW Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BB rats. J Immunol 1997, 159:466-471.
165. Chung YH, Jun HS, Son M, et al. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 2000, 165:2866-2876.
166. Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA Kilham rat virus triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 1996, 45:557-562.
167. + T lymphocytes induces diabetes in resistant BioBreeding/Worcester (BB/W) rats. J Exp Med 1987, 166:461-475.
168. Doukas J, Mordes JP, Swymer C, et al. Thymic epithelial defects and predisposition to autoimmune disease in BB rats. Am J Pathol 1994, 145:1517-1525.
169. Zipris D, Hillebrands JL, Welsh RM, Rozing J, Xie JX, Mordes JP, Greiner DL, Rossini AA Infections that induce autoimmune diabetes in BBDR rats modulate CD4(+)CD25(+) T cell populations. J Immunol 2003, 170:3592-3602.
170. Suenaga K, Yoon JW Association of beta cell-specific expression of endogenous retrovirus with the development of insulitis and diabetes in NOD mice. Diabetes 1988, 37:1722-1726.
171. Gaskins H, Prochazka M, Hamaguchi K, Serreze D, Leiter E Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice. J Clin Invest 1992, 90:2220-2227.
172. Nakagawa C, Hanafusa T, Miyagawa J, et al. Retrovirus gag protein p30 in the islets of nonobese diabetic mice: relevance for pathogenesis of diabetes mellitus. Diabetologia 1992, 35:614-618.
173. Pak CY, Jun HS, Lee M, Yoon JW Beta cell-specific expression of retroviral mRNAs and group-specific antigen and the development of beta cell-specific autoimmunity in non-obese diabetic mice. Autoimmunity 1995, 20:19-24.
174. Fukino-Kurihara H, Fujita H, Hakura A, Nonaka K, Tarui S Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice. Virchows Arch 1985, 49:107-120.
175. Onodera T, Jenson AB, Yoon JW, Notkins AL Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science 1978, 301:529-531.
176. Onodera T, Toniolo A, Ray UR, Jenson AB, Knazek RA, Notkins AL Virus-induced diabetes mellitus. J Exp Med 1981, 153:1457-1465.
177. Onodera T, Ray UR, Melez KA, Suzuki H, Toniolo A, Notkins AL Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature 1982, 297:66-69.
178. Hayashi T, Morimoto M, Iwata H, Onodera T Possible involvement of IL-12 in reovirus type-2-induced diabetes in newborn DBA/1 mice. Scand J Immunol 2001, 53:572-578.
179. Niklasson B, Heller KE, Schonecker B, et al. Development of type 1 diabetes in wild bank voles associated with islet autoantibodies and the novel ljungan virus. Int J Exp Diabetes Res 2003, 4:35-44.
180. Rayfield E, Kelly K, Yoon JW Rubella virus-induced diabetes in hamsters. Diabetes 1986, 35:1276-1281.
181. Tajima M, Yazawa T, Hagiwara K, Kurosawa T, Takahashi K Diabetes mellitus in cattle infected with bovine viral diarrhea mucosal disease virus. J Vet Med A 1992, 39:616-620.
182. Tajima M, Yuasa M, Kawanabe M, Taniyama H, Yamato O, Maede Y Possible causes of diabetes mellitus in cattle infected with bovine diarrhoea virus. Zentralbl Veterinarmed B 1999, 46:207-215.
183. Oldstone MBA Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 1988, 239:500-502.
184. Dyrberg T, Schwimmbeek PL, Oldstone MBA Inhibition of diabetes in BB rats by viral infection. J Clin Invest 1988, 81:928-931.
185. Wilberz S, Partke HJ, Dagnaes-Hansen F, Herberg L Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 1991, 34:2-5.
186. Tracy S, Drescher KM, Chapman NM, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002, 76:12097-12111.
187. Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ, Vague P Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Eur J Immunol 1990, 20:1297-1303.
188. Oldstone MBA Viruses as therapeutic agents: I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J Exp Med 1990, 101:2077-2089.